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INTRODUCTION
Myotonic dystrophy or dystrophia myotonica type 1 (DM1) is an
autosomal dominant genetic neuromuscular disorder, that can be
accompanied by abnormalities in other organs and systems with a
highly variable phenotype. DM1 is caused by an expansion of a CTG
repeat located in the 3 untranslated region of the dystrophia
myotonica protein kinase gene (DMPK) on chromosome 19q (Fu
et al., 1992; Mahadevan et al., 1992). The number of repeats tends
to increase from generation to generation, accounting for the
genetic anticipation characteristic of this disease (Ashizawa et al.,
1992; Mahadevan et al., 1992; Salehi et al., 2007). Healthy individuals
have alleles with 5-35 repeats that are stably transmitted, but when
this number exceeds 50, instability occurs and leads to disease. The
number of CTG repeats is 50-150 in late-onset, mild DM1; 100-
1000 in classic DM1; and more than 2000 in the congenital form.
A significant inverse correlation is noted between onset age and
repeat number and there is a general correlation between the degree
of expansion and the severity of clinical manifestations (Gennarelli
et al., 1996; Hunter et al., 1992).
The neuromuscular clinical manifestations of the disease include
myotonia and progressive muscle weakness, with dystrophic
changes in skeletal muscles including the diaphragm, cranial and
limb muscles (Harper, 2001). The pathology of DM1, however,
extends to other organs and systems and, as such, can be associated
with several significant complications.
Respiratory and cardiac problems have long been recognized as
the main complications of DM1 patients and are the major factors
contributing to mortality. In fact, a study based on a cohort of 115
patients with congenital myotonic dystrophy reported that only
about 50% of patients survived to their mid-30s and that the death
of about 66% of surviving patients is due to respiratory causes
(Reardon et al., 1993). Moreover, large cohort studies have also
reported that respiratory problems are the leading cause of death
(around 40%) in adult-onset DM1 (de Die-Smulders et al., 1998;
Groh et al., 2008; Mathieu et al., 1999). The progressive respiratory
muscle weakness leads to impairment of airway clearance,
inadequate ventilation and respiratory failure (Berry et al., 1996),
whereas no reduction in central airway caliber was found in the
patients with the adult form of DM1 (Fodil et al., 2004). DM1
patients frequently develop pneumonia and respiratory failure as
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SUMMARY
Acute and chronic respiratory failure is one of the major and potentially life-threatening features in individuals with myotonic dystrophy type 1
(DM1). Despite several clinical demonstrations showing respiratory problems in DM1 patients, the mechanisms are still not completely understood.
This study was designed to investigate whether the DMSXL transgenic mouse model for DM1 exhibits respiratory disorders and, if so, to identify
the pathological changes underlying these respiratory problems. Using pressure plethysmography, we assessed the breathing function in control
mice and DMSXL mice generated after large expansions of the CTG repeat in successive generations of DM1 transgenic mice. Statistical analysis of
breathing function measurements revealed a significant decrease in the most relevant respiratory parameters in DMSXL mice, indicating impaired
respiratory function. Histological and morphometric analysis showed pathological changes in diaphragmatic muscle of DMSXL mice, characterized
by an increase in the percentage of type I muscle fibers, the presence of central nuclei, partial denervation of end-plates (EPs) and a significant
reduction in their size, shape complexity and density of acetylcholine receptors, all of which reflect a possible breakdown in communication between
the diaphragmatic muscles fibers and the nerve terminals. Diaphragm muscle abnormalities were accompanied by an accumulation of mutant
DMPK RNA foci in muscle fiber nuclei. Moreover, in DMSXL mice, the unmyelinated phrenic afferents are significantly lower. Also in these mice,
significant neuronopathy was not detected in either cervical phrenic motor neurons or brainstem respiratory neurons. Because EPs are involved in
the transmission of action potentials and the unmyelinated phrenic afferents exert a modulating influence on the respiratory drive, the pathological
alterations affecting these structures might underlie the respiratory impairment detected in DMSXL mice. Understanding mechanisms of respiratory
deficiency should guide pharmaceutical and clinical research towards better therapy for the respiratory deficits associated with DM1.
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a result of alveolar hypoventilation, particularly in the later stages
of the disease (Bogaard et al., 1992; Jammes et al., 1986). Despite
the many clinical examinations showing respiratory failure in DM1
patients, the pathological mechanisms underlying this failure are
still not completely known. Several studies suggest that the causes
of respiratory failure are varied and could be due either to the
involvement of respiratory muscles in the dystrophic and myotonic
process (Bégin et al., 1980; Bogaard et al., 1992; Jammes et al., 1985;
Serisier et al., 1982; Zifko et al., 1996) or to abnormalities in the
nervous system, which generates and controls breathing drive
(Kilburn et al., 1959; Ono et al., 1996; Takasugi et al., 1995).
In neurodegenerative diseases in humans, access to affected
tissue is generally limited to the end-stage of the disease and to
biopsies, making animal models extremely useful (Gomes-Pereira
et al., 2011; Wansink and Wieringa, 2003). In the present study, we
have used DMSXL transgenic mice. These mice express the DMPK
gene in a variety of tissues with a pattern similar to the patterns of
the murine Dmpk gene in mice and the DMPK gene in human
tissues (Huguet et al., 2012). To address whether the DMSXL
transgenic mice animal model, which carry a long CTG repeat and
display DM1 features (Gomes-Pereira et al., 2011), have respiratory
problems, we tested and compared the breathing function in
DMSXL and control mice. To identify the pathological changes
underlying any respiratory complications, we analyzed the
diaphragm muscle and the neural network that generates, controls
and transmits the respiratory rhythm.
RESULTS
Impaired respiratory function in DMSXL mice
To investigate whether the DMSXL transgenic mice have
respiratory alterations, we first measured, under the same
conditions, the most relevant respiratory parameters in awake
young or adult DMSXL and control (wild-type and DM20) mice.
The analysis of breathing patterns (Fig. 1) and parameters recorded
in young awake mice (2 months old) revealed a small but significant
decrease in tidal volume (TV) and volume per minute (minute
volume, MV) in DMSXL mice.
We noticed that awake mice, especially the DMSXL mice,
appeared highly stressed and agitated during recording, and so we
assessed the respiratory function in anesthetized mice. The results
of these experiments showed that in 2-month-old anesthetized
mice, the respiratory rate (RR) and the TV were significantly
decreased in DMSXL mice compared with control mice taken from
the same litter and with DM20 mice that do not express the DM1
phenotype (wild type and DM20). Consequently, the mean value
for minute volume/body weight (tidal volume × breathing
frequency/body weight) was also reduced in DMSXL mice (Table
1). In addition, a significant reduction was detected in arterial blood
oxygen saturation (SpO2) in DMSXL mice. Overall, we found that
alterations in respiratory function observed in young DMSXL mice
did not really change as a function of age. In fact, measurement of
respiratory parameters in 6-month-old mice confirmed the
decrease in RR, TV, MV and SpO2 in DMSXL mice (Table 2). To
be sure that the alterations in respiratory pattern observed in
DMSXL mice are not related to their small size, we measured the
respiratory function in wild-type mice having similar size and
weight (24±0.6 g). The results of these experiments showed no
changes in RR and in SpO2 in the small control mice compared
with normal control mice (RR, 135.7±8.2 in small control versus
126±15.1 in normal control; SpO2, 98.23±0.21 versus 98.62±0.38).
TRANSLATIONAL IMPACT
Clinical issue
The multisystemic autosomal dominant disorder myotonic dystrophy type1
(DM1), also known as Steinert disease, is the commonest form of adult-onset
muscular dystrophy. DM1 is caused by abnormal expansion of CTG
trinucleotide repeats in the region of DMPK, the gene encoding DM protein
kinase. Respiratory failure is a major and potentially life-threatening feature of
patients with DM1, but the pathological mechanisms of respiratory failure in
DM1 are incompletely understood. Some studies suggest that the respiratory
problems associated with DM1 result only from the involvement of the
respiratory diaphragm muscle in progressive dystrophic and myotonic
processes, whereas others suggest that the neuronal network that generates
and regulates the respiratory rhythm is also involved. 
Results
Because it is not feasible to take biopsies of the nervous system from
patients with DM1 for histological examinations, animal models are
indispensable for the study of the mechanisms underlying respiratory
failure in this disease. In this study, the authors test the respiratory function
and analyze the structures involved in respiratory function in DMSXL
transgenic mice, an established animal model for congenital DM1 (the severest
form of the disease, which develops at birth) that carries a very long CTG
repeat in the DMPK gene. Statistical analysis of breathing function
measurements shows that DMSXL mice have impaired respiratory function.
Histological and morphometric analyses reveal pathological changes in the
diaphragmatic neuromuscular junctions and muscle fibers of DMSXL mice and
a significant decrease in the number of unmyelinated phrenic afferents. By
contrast, DMSXL mice exhibit no significant neuronopathy in either cervical
phrenic motor neurons or brainstem respiratory neurons. 
Implications and future directions
By shedding new light on the cellular mechanisms of respiratory failure in
DM1, these findings improve understanding of the main cause of death in
congenital DM1. The denervation and the pathological changes of the
diaphragmatic neuromuscular junctions observed in DMSXL mice suggest that
a breakdown in communication between the diaphragmatic muscle fibers and
the nerve endings might be the main cause of respiratory failure; the loss of
phrenic unmyelinated afferents suggests that altered regulation of breathing is
also involved. As well as contributing towards the understanding of respiratory
failure in DM1, these findings suggest that the evaluation of respiratory
parameters in DMSXL mice by non-invasive pressure plethysmography could
be used to evaluate the effect of potential therapies. Moreover, future analyses
of gene expression in DMSXL mice might contribute to our understanding of
the molecular mechanisms involved in respiratory impairment. 
Fig. 1. Typical breathing patterns. Representative recordings showing
typical examples of breathing patterns over a 4-second snapshot in 6-month-
old awake (A,B) and anesthetized (C,D) wild-type (A,C) and DMSXL mice (B,D).
Scale bar: 0.5 seconds.
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This result ruled out the possibility that the respiratory alterations
observed in DMSXL mice are caused by their small size. Moreover,
the comparison and statistical analysis of all our results revealed
two points: first, the breathing function in DM20 transgenic mice,
which do not express the phenotype of DM1 disease, was similar
to that in wild-type mice; and second, anesthesia caused a reduction
in breathing parameters in all mice compared with awake mice.
Pathological changes in diaphragmatic muscle fibers and
neuromuscular junctions
To assess whether modifications in the diaphragm are responsible
for the impairment in respiratory function in DMSXL mice, we
first examined diaphragm sections stained for either ATPase
activity or with hematoxylin and eosin (H&E). In both control (wild
type and DM20) and DMSXL mice, we observed that the majority
of fibers did not show phosphorylase activity and were only
counterstained with Luxol Fast Blue (>85% type II); a small number
of fibers were strongly stained (type I) (Fig. 2). However,
quantification of muscle fibers showed an increase (14.7%) in the
mean percentage of type I fibers in DMSXL mice compared with
control mice. Other dystrophic alterations were observed in
DMSXL diaphragm sections, such as centrally located nuclei, an
increase in interfasicular connective tissue and the presence of
infiltrating inflammatory cells (Fig. 2). The abnormality of DMSXL
diaphragm muscle was accompanied by an accumulation of DMPK
RNA with its expanded CUG repeat, found as foci in the nuclei of
muscle fibers (Fig. 3). About 58% of DMSXL diaphragm muscle
fiber nuclei contained between one and seven foci, with an average
of 2.2 foci per affected nucleus. No nuclear RNA foci were detected
in the diaphragm muscle fibers of control mice.
The diaphragm neuromuscular junctions (NMJs) also underwent
pathological changes in DMSXL mice. Despite the presence of
bundles of axons in the serial muscle sections, about 20% of the
endplates were denervated and had no contact with nerve
terminals. Moreover, numerous EPs exhibited lengthened shapes
and faint labeling compared with controls (Fig. 4). Statistical
analysis of the morphometric results confirmed the abnormality
of EPs in DMSXL mice. A significant decrease in mean EP area
(11%) and shape complexity (16.3%) was found in DMSXL mice,
as well as in the density of acetylcholine receptors (AChRs) on
postsynaptic membranes (reduced by 19.9%; Fig. 4). Combined
staining with α-BTX and FISH (see Materials and Methods)
revealed that several foci were located in sub-synaptic nuclei.
Severe loss of phrenic nerve unmyelinated axons
Light microscopy revealed no obvious morphological differences
between control (wild type and DM20) phrenic nerve transverse
sections of DMSXL mice, except for the smaller size of DMSXL
nerve sections. In all animals, the phrenic nerve consisted of a single
fascicle containing myelinated and unmyelinated axons. In electron
microscopy analysis, apart from some pathological signs (aberrant
Schwann cell proliferation, increased number of macrophages)
observed on DMSXL thin nerve sections, a severe and significant
loss (41%; P<0.01) in the number of unmyelinated axons was found
(Fig. 5). By contrast, the number of myelinated fibers showed a
slight but not significant decrease (5%; P0.30), although the
thickness of myelin sheath was reduced significantly (P<0.01) in
DMSXL mice compared with controls (628±9 nm versus 770±54
nm). FISH analysis showed that several Schwann cells that
intermingled with axons contained one or two ribonuclear foci in
their nuclei (Fig. 5).
Absence of significant alterations in phrenic motor or brainstem
respiratory neurons in DMSXL mice
Histological examination of cervical phrenic motor neurons showed
rare apoptotic features (nuclear eccentricity, loss of Nissl bodies or
cytoplasm granulation). The estimation of the number of neurons
by the physical disector method revealed a slight but not significant
decrease (5%; P0.13) in the mean number of cervical phrenic
motor neurons in DMSXL mice. In addition, only a few mRNA
foci were observed in phrenic motor neurons in DMSXL mice.
The histological and morphometric analysis of five brainstem
disector pairs containing respiratory neurons located in a region
that extends from the compact portion of the nucleus ambiguus
to just behind the facial motor nucleus (Fig. 6) ruled out the
presence of neuronopathy in DMSXL mice respiratory neurons. In
Table 1. Mean values of respiratory parameters in 2-month-old anesthetized wild-type and DM1 transgenic mice  
Respiratory parameter 
Wild-type mice 
(BW=28.5±0.6 g) 
DM20 mice 
(BW=28.0±0.8 g) 
DMSXL mice 
(BW=20.2±0.8 g) P1 P2 P3 
RR (breaths/minute) 126.2±15.1 124.5±18.6 86.2±7.6 ns <0.01 <0.05 
TV (ml) 0.312±0.024 0.281±0.046 0.226±0.034 ns <0.01 <0.01 
MV (ml)  39.61±7.82 35.05±5.76 19.43±2.68 ns <0.01 <0.05 
TV/BW (ml/g) 0.011±0.001 0.010±0.001 0.011±0.001 ns ns ns 
MV/BW (ml/g) 1.43±0.23 1.25±0.19 0.96±0.14 ns <0.01 <0.05 
SpO2 (%) 98.62±0.38 97.85±1.13 94.23±1.47 ns <0.01 <0.01 
HR (beats/minute) 574±48 630±64 619±40 ns ns ns 
Values are mean ± s.d.; n=5. HR, heart rate; BW, body weight; P1, comparisons between wild-type and DM20 mice; P2, comparisons between wild-type and young DMSXL mice;  
P3, comparisons between DM20 and young DMSXL mice; ns, non-significant. 
Table 2. Mean values of respiratory parameters in 6-month-old 
anesthetized wild-type and DM1 transgenic mice 
Respiratory 
parameter 
Wild-type mice 
(BW=33.8±3.6 g) 
DMSXL mice 
(BW=22.2±2.0 g) P 
RR (breaths/minute) 125.7±14.4 87.8±5.3 <0.01 
TV (ml) 0.381±0.041 0.228±0.013 <0.01 
MV (ml)  47.72±11.01 20.48±1.33 <0.01 
TV/BW (ml/g) 0.011±0.001 0.010±0.001 <0.01 
MV/BW(ml/g) 1.4±0.17 0.94±0.09 <0.05 
Values are mean ± s.d.; n=5. BW, body weight; ns, non-significant. 
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fact, the histological examination of respiratory neurons located
in the area of the ventrolateral nucleus of the solitary tract and
neurons scattered in the vicinity of the nucleus ambiguus and the
surrounding reticular formation did not reveal apoptotic features.
Moreover, the physical disector estimation of neuron density
showed only a non-significant reduction (3%) in the density of
DMSXL respiratory neurons as compared with controls.
DISCUSSION
The major result provided by this study is the demonstration that
DMSXL mice, a transgenic mouse model of DM1, have respiratory
impairments characterized by a significant decrease in RR, TV,
MV and SpO2 compared with control mice. The second important
result is the detection of a partial denervation of diaphragmatic
EPs and significant pathomorphological changes in diaphragm
EPs and muscle fibers in DMSXL mice, which indicate a possible
breakdown in communication between the diaphragmatic
muscles fibers and the nerve terminals. Also, a severe and
significant loss in the number of phrenic unmyelinated afferents
was detected in DMSXL mice, whereas no significant alterations
were observed in phrenic motor neurons or brain stem respiratory
neurons.
Taking into consideration that the diaphragm muscle is the
principal respiratory muscle and that afferent phrenic unmyelinated
fibers are involved in control of the basic respiratory rhythm, we
believe that the pathological changes observed in the diaphragm
and phrenic nerve afferents in DMSXL mice are responsible for
the respiratory failure assessed in these mice. Because central
neurons did not show significant neuronopathy, the generation of
the breathing rhythm is probably not affected in DMSXL mice.
Impaired respiratory function in DMSXL mice
For the study of mechanisms of myotonic dystrophy diseases, there
is a growing use of various animal models (Gomes-Pereira et al., 2011;
Wansink and Wieringa, 2003). Consequently, some of the same
techniques used in the clinic to examine patients should be adapted
for analysis in animal models. Several studies reported that pressure
plethysmography can serve as a valuable respiratory function test in
conscious or anesthetized small animals. This non-invasive method
is particularly appropriate for quick and repeatable screening of
respiratory function over short and extended periods of time for large
numbers of mice and rats. Moreover, the intra-individual variability
in respiratory function measured by pressure plethysmography is
acceptable (Huang et al., 2011; Stunden et al., 2001; Yilmaz et al.,
2005). Therefore, in the current study we used pressure
plethysmography to assess the respiratory function in DMSXL and
control mice. The comparison and the statistical analysis of several
breathing measurements demonstrated a significant decrease in most
relevant respiratory parameters in anesthetized DMSXL mice,
indicating an impairment in breathing function in young and adult
mice. Because alterations in the breathing parameters observed in
young mice do not become more severe in adult animals, we inferred
that respiratory impairment in DMSXL mice does not depend on
the age of the animals. We also demonstrated that respiratory changes
including RR and SpO2 were not related to the small weight of the
DMSXL transgenic mice. In addition, the hypothesis that the
respiratory abnormalities observed in these mice are due to
overexpression of the genes carried by the transgene is excluded
because the DM20 transgenic mice carrying the same transgene but
with a normal number of CTG repeats did not show alterations in
respiratory function compared with wild-type mice.
Fig. 2. Cross-diaphragm muscle sections of 2-month-old mice. Wild-type (A,D), DM20 (B,E) and DMSXL (C,F) mice were labeled either for myofibrillar ATPase
activity after pre-incubation at pH 4.2 (A-C), or with H&E (D-F). On ATPase-stained sections, two main fiber types can be observed in control and DMSXL mice.
(A,B)In wild-type and DM20 control mice, there are 90% ATPase unstained fibers (fast-twitch type II fibers), only stained with Luxol Fast Blue, and 10% are ATPase
darkly stained fibers (slow-twitch type I fibers). (C)In DMSXL mice, a slight increase (11.5%) in the number of fast-twitch type I fibers was counted. 
(D-F)Diaphragm muscle sections were taken from wild-type and DM20 control mice (D,E) and DMSXL mice (F) stained with H&E. The presence of interfasicular
connective tissue, inflammatory cells and central nucleated fibers (arrowheads) can be easily observed on DMSXL sections (F). Scale bars: 50 μm.
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Statistical analysis of the results of several recordings showed
that the mean values of respiratory parameters in anesthetized mice
were reproducible and comparable with values previously reported
(Daubenspeck et al., 2008; Hamelmann et al., 1997; Hoymann, 2007;
Huang et al., 2011). Several studies reported that the breathing
frequency decreases by about 40-60% in anesthetized mice
compared with conscious mice (Hamelmann et al., 1997; Takezawa
et al., 1980). In our study, the RR and MV were decreased under
anesthesia to about 47% in controls and 34% in DMSXL mice
compared with conscious animals, which indicates that DMSXL
mice are more sensitive to anesthesia. In agreement, clinical reports
have mentioned that, in general, patients with DM1 disease present
potential respiratory depression during or after anesthesia, although
the mechanisms underlying the anesthesia effect on respiratory
depression in DM1 patients is not well investigated (Ogawa et al.,
1993; Yomosa et al., 1991). It is conceivable that in DMSXL mice
anesthesia acts directly on the neural network that generates,
controls and transmits the respiratory rhythm and also acts on the
diaphragm, which is the main respiratory muscle. Another
possibility is that the anesthesia has an effect on several areas of
the central nervous system, which in turn exert an influence on
the structures involved in respiratory function.
Because DMSXL mice displayed impairment in respiratory
function, these mice present a useful tool for investigating the
pathological changes underlying the respiratory failure associated
with DM1 disease. Importantly, the evaluation of respiratory
parameters by non-invasive pressure plethysmography could be
used to evaluate the effect of potential therapies in DMSXL mice.
Role of pathological changes in the DMSXL diaphragm in
respiratory impairment
Anatomical and electrophysiological data suggest that the basic
breathing rhythm of higher mammals is generated and regulated
in brainstem respiratory neurons. Then, the stimuli are transmitted
via cervical phrenic motor neurons and phrenic nerves to the
diaphragmatic muscle, which is the principal respiratory muscle
(Ramirez et al., 2002). Therefore, the impairment in respiratory
function observed in DMSXL mice might have a central origin in
decreased respiratory drive, or a peripheral origin such as weakness
of the diaphragmatic muscles, or both.
Because diaphragmatic muscle is the only effective respiratory
muscle pump and its action contributes to more than 66% of the TV
(Mead et al., 1995; Singh et al., 2003), our efforts were focused on
analyzing diaphragm muscle fibers and NMJs. Several of the
alterations observed in DMSXL diaphragm muscle lead us to believe
that they might cause, at least partially, the respiratory failure in these
mice. In fact, the increase in histochemically defined type I muscle
fibers, the presence of central nuclei, the gain in interfasicular
connective tissue and inflammatory cells, as well as the accumulation
of expanded CUG mRNA in muscle fiber nuclei all indicate that the
diaphragm muscle of DMSXL mice is involved in the dystrophic
processes. This assumption can be supported, on the one hand, by
the presence of similar histopathological changes in biopsies of DM1
patients (Harper, 1989; Romeo, 2012) and, on the other hand, by the
changes in fiber type composition of the diaphragm muscles in an
animal model of Duchenne muscular dystrophy, which is
characterized by severe muscle degeneration (Guido et al., 2010;
Petrof et al., 1993). These authors hypothesize that the progressive
changes in fiber type probably permit better adaptation of the muscle
to its function during progression of the disease. It is possible that
the increased number of type I diaphragm fibers (slow-twitch) in
DMSXL mice, due to a selective degeneration of type II fibers (fast-
twitch), probably causes alterations in diaphragmatic muscle function
in these mice.
The detection of an accumulation of CUG expanded RNA as
foci in diaphragm muscle fiber nuclei is another indication of the
abnormality of the DMSXL diaphragm. The presence of foci and
the sequestration of muscleblind protein in the nuclei diaphragm
NMJs has also been reported in DM1 muscle biopsies and in
another DM1 transgenic mouse model (Wheeler et al., 2007). It is
well known that the main pathogenic process at the base of DM1
is a toxic RNA gain-of-function effect of mutant DMPK transcripts,
which are retained in distinct ribonuclear foci within the cell nuclei.
Taking into consideration this hypothesis, inferring that these
nuclear foci sequester essential proteins and disrupt their normal
function in the cell (Kuyumcu-Martinez and Cooper, 2006; Nykamp
and Swanson, 2008; Querido et al., 2011), we can hypothesize that
nuclear retention of mutant DMPK mRNA in diaphragmatic
muscle fibers alters the function of the diaphragm, which can lead
to respiratory failure.
Fig. 3. Detection of nuclear foci by FISH on frozen sections of diaphragm
muscle prepared from 2-month-old DMSXL mice. Using the Cy3-labeled
CAG-repeats PNA-probe, the RNA inclusions are labeled in red within the
nuclei of muscle fibers stained in blue with DAPI. (A)Low magnification image
shows numerous nuclei stained in blue surrounding the diaphragm muscle
fibers. (B,C)At higher magnification the presence of one or more foci inside
the nuclei is easily observed. Scale bars: 20 μm (A); 5 μm (B,C).
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In DMSXL mice, the diaphragmatic NMJs also undergo
pathological changes. About 20% of diaphragm EPs were
denervated and the area and the shape complexity of EPs were
significantly reduced. Moreover, the AChR density on postsynaptic
membranes was significantly lower. It should be noted that in
previous experiments in DM1 transgenic mice carrying only 500
CTG repeats we detected similar abnormalities in the structure of
diaphragmatic EPs (Panaite et al., 2008). The fact that the statistical
analysis revealed that the pathological changes in diaphragmatic
EPs found in DMSXL mice, carrying about 1300 CTG repeats, do
not vary significantly from those observed in DM1 mice indicates
that there is no relationship between the severity of EP alterations
and length of the CTG repeat. This is consistent with clinical studies
reporting that some DM1 features such as cataract, sleep disorders,
gastrointestinal problems, respiratory insufficiency and cardiac
abnormalities do not correlate with the size of the unstable base
CTG triplet (Jaspert et al., 1995; Marchini et al., 2000).
It is quite possible that the denervation and abnormalities seen
in EP structure are induced by the loss of 5% of phrenic myelinated
fibers and also by the alterations affecting muscle fibers. A recent
study reported that one of the mechanisms underlying the
impairment of neuromuscular connections observed in DM1 tissue
cultures is the misexpression of two members of the SLITRK family
genes, which are involved in neurite outgrowth, neuritogenesis and
synaptogenesis (Marteyn et al., 2011).
Because the normal function of the diaphragm in both
inspiratory and expiratory phases of breathing requires neural
stimulation via normal NMJs, the damage and alterations to the
phrenic nerve affect the diaphragmatic DMSXL NMJs and probably
results in failure of action potential transmission (Andreose et al.,
1995; Kumai et al., 2005). Numerous clinical data report that
patients with signs of muscular weakness and myotonia also show
respiratory impairment (Bégin et al., 1997; Jammes et al., 1985;
Serisier et al., 1982; Zifko et al., 1996), therefore, the pathological
changes observed in DMSXL diaphragm muscle are probably
sufficient to affect the normal function of the diaphragm during
breathing in these mice.
Role of alterations in phrenic afferents in breathing impairment in
DMSXL mice
In addition to the motor function, the phrenic nerve is also rich
(43%) in afferent axons composed mainly of unmyelinated axons.
The motor component of the phrenic nerve is mainly myelinated
whereas the sensory component is mainly unmyelinated (Langford
and Schmidt, 1983). The thin afferent fibers are believed to be
connected to polymodal receptors on the surface of the muscle
and within the muscle. Free nerve endings located in muscle are
presumed to represent these receptors (Brown and Fyffe, 1978;
Duron and Marlot, 1980; Goshgarian and Roubal, 1986; Kumazawa
and Mizumura, 1977). Groups of these fibers are activated
principally by chemical stimuli rather than by mechanical stimuli
(Kumazawa and Mizumura, 1977).
The tracer combination of the anterogradely transported Fast
Blue and the retrogradely transported Nuclear Yellow allowed the
demonstration that some phrenic nerve afferents terminate at the
C4 and C5 spinal cord in rats (Revelette et al., 1988). Other afferents
project to the brain stem nuclei, including dorsal respiratory group
neurons (DRG) and ventral respiratory group neurons (VRG)
(Larnicol et al., 1985; Macron et al., 1985; Marlot and Duron, 1981).
The neurons in the DRG and VRG in the brain stem are primarily
responsible for the generation of the rhythmic pattern of respiration.
However, there is growing evidence that diaphragmatic afferent
stimuli exert a modulating influence on the basic respiratory
rhythm, although they do not play a crucial primary role in
generating or maintaining the rhythm.
Electrical stimulation of phrenic nerve afferents during
inspiration produce a premature transition from the inspiratory to
expiratory phase, and it was concluded that phrenic afferents exert
Fig. 4. Pathological changes in neuromuscular junctions of
DMSXL mice. (A-F) Representative micrographs of diaphragm
muscle cryostat sections that were stained with rhodamine α-BTX
(red) and neurofilament antibody (green). (A-C)In wild-type
control mice practically all the EPs are innervated by branches of
axons. (D-F)In DMSXL mice, EPs with no contact to axon terminals
are easily identified. (C,F)A single EP is shown at higher
magnification. In DMSXL mice (D-F), the EPs have smaller size and
less complex shape than in control mice (A-C). The mean surface
area of EPs, the shape complexity and the density of acetylcholine
receptors on post-synaptic membranes labeled with rhodamine α-
BTX are represented in the three histograms. More than 1500 EPs
were measured from each mouse line (n7). Statistical analysis of
the results reveals that all three parameters are significantly
(**P<0.01) smaller in DMSXL mice compared with wild-type
control mice. Scale bars: 100 μm (A,D); 50 μm (B,E); 20 μm (C,F).
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an inhibitory influence on inspiratory motor drive (Jammes et al.,
1986; Marlon et al., 1988). However, other studies report that the
activation of small-fiber afferents in the diaphragm of anesthetized
dogs induces a marked excitatory effect on phrenic motor neurons
and brain stem respiratory neurons (Revelette et al., 1988; Speck
and Revelette, 1987). These studies concluded that the phrenic
nerve afferent populations are capable of producing at least two
distinct effects: a net excitation of inspiratory activity at the pre-
motor level and a strong inhibitory effect on motor output at the
spinal level.
In our current study, the statistical analysis of morphometric
results showed a severe loss of unmyelinated phrenic afferents
(>40%), whereas phrenic myelinated fibers undergo a slight and
non-significant reduction (5%). Furthermore, the phrenic motor
neurons and the brainstem respiratory neurons do not suffer from
significant neuronopathy because only a small non-significant loss
in the number of neurons was found. With reference to the data
reported in the studies mentioned above, we can deduce that in
DMSXL mice the afferent feedback is reduced and the regulation
of respiratory drive is altered, whereas the generation of breathing
rhythm is probably not affected.
In summary, despite the large cohort studies showing that
respiratory problems are the leading cause of death, especially in
surviving patients with congenital DM1 (Reardon et al., 1993), and
to a lesser degree in adult-onset DM1 (de Die-Smulders et al., 1998;
Groh et al., 2008; Mathieu et al., 1999), the pathological mechanisms
underlying respiratory failure are still not completely known.
Our study in a transgenic mouse model of DM1 sheds light on
possible mechanisms of respiratory failure, because the respiratory
impairments seen in these mice are caused by pathological changes
affecting mainly the diaphragm respiratory pump and phrenic
unmyelinated afferents. Because cervical phrenic motor neurons
and brainstem respiratory neurons do not show significant
neuronopathy, the generation of the breathing rhythm is probably
not affected in DMSXL mice.
MATERIALS AND METHODS
All experiments were carried out in accordance with the local
veterinary guidelines for care and use of experimental animals and
all analyses and counts were performed blinded to the animal
genotype.
Generation of the DM1 animal model
The generation of transgenic mice carrying the human genomic
DM1 region with expanded repeats of either ~500 CTG (DM1 mice;
displaying mild DM1 phenotype) or 20 CTG (normal; do not
develop DM1 phenotype) has been described previously (Gantelet
et al., 2007; Seznec et al., 2001). DMSXL mice carrying more than
1300 CTG were obtained from DM1 mice, after large expansions
of the CTG repeat over successive generations (Gomes-Pereira et
al., 2007; Panaite et al., 2011). Expression of expanded CUG leads
to the formation of numerous foci that co-localize with
muscleblind-like protein 1 and 2 (MBNL1 and MBNL2). Mild
missplicing of target RNA is observed in muscles and heart tissues.
These molecular features of DM1-associated RNA toxicity were
associated with high mortality, growth retardation and muscle
defects (abnormal histopathology, reduced muscle strength and
lower motor performances) (Huguet et al., 2012).
Heterozygous mice, homozygous and wild-type mice are
obtained by breeding from the same litter. Only homozygous
transgenic mice were used in our study because the heterozygous
mice expressing a low level of DMPK transcripts do not have an
obvious phenotype. Thirty mice were used: group 1 consisted of
five 2-month-old DMSXL mice and five control mice taken from
the same litter (body weight 20.2±1.1 g versus 27.6±0.8 g); group
2 consisted of five 2-month-old DM20 mice and five control mice
(body weight 28.0±0.6 g versus 28.5±0.8 g); and group 3 consisted
of five 6-month-old DMSXL mice and five control mice (body
weight 22.0±2.0 g versus 33.8±3.6 g).
Respiratory function analysis (pressure plethysmography
protocol)
To investigate whether the DMSXL mice have respiratory failure,
we measured the breathing function in DMSXL and control mice
using pressure plethysmography (Respiromax system, Columbus
Instruments, Columbus, OH), a precise method adapted for both
awake and anesthetized small animals (Stunden et al., 2001; Yilmaz
Fig. 5. Pathological changes in phrenic nerves of DMSXL mice. 
(A,B) Representative electron micrographs of ultrathin transverse phrenic
nerve sections taken from 6-month-old wild-type (A) and DMSXL transgenic
mice (B). On sections from control mice, numerous unmyelinated axons
surrounded by a Schwann cell can be observed (A), whereas on the DMSXL
mice section (B) the presence of unmyelinated axons is less frequent than in
control mice. (C,D)On frozen sections prepared from DMSXL phrenic nerve,
the FISH combined with neurofilament immunostaining demonstrates the
presence of CUG RNA foci (red) in Schwann cell nuclei (blue), which are
intermingled with the axons (green). (E,F)Histograms show the mean number
of unmyelinated fibers (E) and myelinated fibers (F) counted on ultrathin
phrenic nerve sections taken from seven wild-type mice and seven DMSXL
mice. **P<0.01. Scale bars: 1 μm (A,B); 10 μm (C); 2 μm (D).
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
Disease Models & Mechanisms 629
Breathing impairment in DM1 animal model RESEARCH ARTICLE
et al., 2005). Individual mice were first weighed then placed in a
respiromax cylindrical chamber. A tail rod was moved forward until
it secured the animal, preventing it from backing up and
maintaining a prone position. The head of the animal emerged
through an inflatable latex cuff into a head chamber and the neck
cuff was pressurized to seal the body chamber. Each mouse was
allowed to acclimatize to the plethysmography chamber for ~5
minutes before tests began. A sensitive transducer measured the
changes in pressure in the body chamber caused by the animal’s
respiration. Signals from the pressure transducer were amplified
and digitized by a respiratory function software (Columbus
Instruments), displayed and stored in a computer for graphical and
statistical analysis. In all experiments, the temperature of the body
chamber was continuously monitored using a thermal probe. The
following parameters were evaluated: tidal volume (ml), respiratory
rate (breaths/minute), minute volume (tidal volume multiplied by
respiratory rate, ml/minute). The respiratory function of each
mouse was tested several times over a period of 2 weeks.
In another series of experiments, the respiratory function was
measured in mice anesthetized with isoflurane using a Matrx
Quantiflex low flow V.M.C. anesthesia system (Midmark, Versailles,
OH). The animals were placed individually in an induction chamber
and anesthesia was induced with 5% isoflurane in a gas mix of
O2/N2O2 (30/70%). The animals were then quickly placed inside
the Respiromax system, with a 1.5% isoflurane flow in the head
chamber in the same O2/N2O2 gas mix. A MouseOx pulse oximeter
(Starr Life Sciences, Oakmont, PA) was placed on the upper, right
hindleg of each mouse to measure the oxygen saturation of arterial
hemoglobin (SpO2) and heart rate; the body chamber was closed
and the neck cuff swollen. Animals were allowed to settle for 5
minutes before the first set of measurements.
Animal perfusion and tissue preparation
After testing the respiratory function, mice were deeply
anesthetized and the brainstem, cervical spinal cord, right and left
phrenic nerves and diaphragm muscles carefully removed from
each animal as previously described (Panaite et al., 2008; Panaite
et al., 2011).
Analysis of diaphragm muscle sections
To examine diaphragm muscle fibers, 10-μm thick transverse
cryostat sections were prepared and myofibrillar adenosine
triphosphatase (ATPase) activity assessed after pre-incubation at
pH 4.2 (Sheehan and Hrapchak, 1980) followed by counterstaining
with Luxol Fast Blue. Other sections were stained with hematoxylin
and eosin (H&E). The number of each fiber type was assessed using
an image-processing program (ImageJ 1.40, National Institutes of
Health, Bethesda, MD). To analyze the NMJs, serial longitudinal
cryostat sections (20-μm thick) of diaphragm muscle were double
labeled with tetramethylrhodamine-conjugated α-bungarotoxin
(α-BTX; Invitrogen, Life Technologies, Carlsbad, CA,) and with a
primary polyclonal antibody directed against the 200-KDa
neurofilament protein (AB1982, Millipore, Billerica, MA).
Muscle sections were observed under a Zeiss AxioPlan 2
microscope (Zeiss; Oberkochen, Germany), photographed using
an image-acquisition program (Zeiss AxioVision with Axiocam
HRc) and images systematically analyzed in the ImageJ 1.40
program. The percentage of denervated endplates (EPs) was
estimated and the morphometric parameters (area, shape
complexity and fluorescence intensity of rhodamine-α-BTX
labeling) of each EP were measured and calculated as described in
our previous studies (Panaite et al., 2008; Panaite et al., 2011). More
than 1500 EPs were measured from each mouse line (n7 DMSXL
and control mice).
Detection of nuclear RNA foci
Fluorescence in situ hybridization (FISH) was performed on 7-
μm thick frozen sections as described by Guiraud-Dogan et al.
(Guiraud-Dogan et al., 2007). In short, sections of diaphragm
muscle, phrenic nerve, cervical spinal cord and brain stem were
dried, fixed, then incubated in 30% (v/v) formamide and 2×
standard sodium citrate (SSC) for 10 minutes, hybridized with
the PNA probe Cy3-OO-CAGCAGCAGCAGCAG (1 ng/μl)
(Eurogentec, Liège, Belgium) for 2 hours at 37°C in buffer [30%
(v/v) formamide, 2× SSC, 0.02% (w/v) BSA, 66 μg/ml yeast tRNA
(Invitrogen) and 2 mM vanadyl complex (Sigma-Aldrich, St
Louis, MO)]. Sections were then washed for 30 minutes in 30%
Fig. 6. Analysis of brainstem respiratory nuclei by the physical
disector method. (A,B) Caudal and rostral disector pairs. The density
of respiratory neurons located in a region extending from the nucleus
ambiguus (caudal disector pair sections) and facial motor nucleus
(rostral disector pair sections) was estimated by the physical disector
method. Five disector pairs were analyzed from each animal (n5). 
(C-E)The two sections of a dissector pair were overlaid one on top of
the other using Adobe Photoshop CS5 and carefully aligned using
common landmarks (general contour, brain stem nuclei, blood
vessels, etc); then the neurons present in the front (C) and back (D)
sections were marked with two different types of symbols. The set of
symbols from the back section were superimposed on the ones from
the front section (E) and the neurons present only in the front but not
in the back section were counted and used to estimate the density of
neurons. AN, nucleus ambiguus; FN, facial nucleus; SN, solitary tract
nucleus; STN, spinal tract of the trigeminal nerve nucleus. Scale bars:
500 μm (A,B); 25 μm (C-E).
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(v/v) formamide and 2× SSC at 50°C and then for 30 minutes
in 1× SSC at 20°C. Nuclei were stained by incubating with DAPI
for 15 minutes at room temperature. The cervical spinal cord,
phrenic nerves and brain stem sections were additionally labeled
with polyclonal anti choline-acetyltransferase antibody (ChAT,
1:50; AB144P, Millipore) as previously described (Panaite et al.,
2011).
Analysis of phrenic nerve sections
For light microscopy analysis, semithin transverse sections (1 μm)
were cut at different levels from phrenic nerve trunks and stained
with Toluidine Blue. For electron microscopy examination, ultrathin
sections (80 nm) were cut and contrasted with uranyl acetate and
lead citrate. Sections were viewed in the Zeiss EM 10C electron
microscope and morphometric analysis was performed as
previously described (Gantelet et al., 2007; Panaite et al., 2008).
The number of myelinated and unmyelinated axons was counted
and the thickness of the myelin sheath calculated (n7 for each
DMSXL and controls).
Analysis of cervical phrenic motor neurons and brainstem
respiratory neurons
Serial transverse cryostat sections (20 μm) were prepared from
cervical spinal cords (C3-C5) and from brainstems (caudal and
rostral to the obex). Sections were either immunolabeled with
polyclonal anti-ChAT antibody, which labels motor neurons, or
stained with Toluidine Blue. The physical disector method was used
to estimate the number of motor neurons in 2-mm segments of
either cervical spinal cord or the medullary reticular formation.
Identification of respiratory neurons on brainstem sections was
achieved according to their localization, as described in several
studies (Alheid et al., 2002; Kuwana et al., 2006; Stornetta, 2008).
The physical disector method is based on sampling sections, called
disector pairs. Four or five disector pairs were used from each
animal to estimate the density of neurons, as previously described
(Panaite et al., 2011).
Data analysis and statistics
Each respiratory parameter for each mouse (TV, RR, MV, MV/g,
heart rate, oxygen saturation) and the data obtained from the
diaphragm, phrenic nerves, cervical spinal cord and brainstem
examinations were analyzed and compared. ANOVA was used to
determine significant difference between the groups, followed by
Bonferonni-Holm post-hoc test. Pair-groups were compared by
Student’s t-test. In all cases, plethysmograph data were normalized
to the weight of the animal. Values are reported as mean ± s.d.;
P<0.05 was considered a significant difference. All statistical
analyses and histograms were performed using GraphPad Prism
software (GraphPad Software, La Jolla, CA).
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